BUTABARB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Butabarb, and what generic alternatives are available?
Butabarb is a drug marketed by Alpharma Us Pharms, Bundy, Wockhardt, Sandoz, Solvay, Teva, Watson Labs, and Whiteworth Town Plsn. and is included in seventeen NDAs.
The generic ingredient in BUTABARB is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
Summary for BUTABARB
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Patent Applications: | 3,657 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BUTABARB at DailyMed |